Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Non-Current Deffered Revenue (2016 - 2019)

Healthequity has reported Non-Current Deffered Revenue over the past 6 years, most recently at $3.0 million for Q1 2019.

  • For Q1 2019, Non-Current Deffered Revenue rose 23.92% year-over-year to $3.0 million; the TTM value through Jan 2019 reached $3.0 million, up 23.92%, while the annual FY2019 figure was $3.0 million, 23.92% up from the prior year.
  • Non-Current Deffered Revenue for Q1 2019 was $3.0 million at Healthequity, up from $2.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $3.0 million in Q1 2019 and troughed at $145000.0 in Q3 2015.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2016 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 66.67% in 2015 and later surged 642.07% in 2016.
  • Year by year, Non-Current Deffered Revenue stood at $195000.0 in 2015, then surged by 564.1% to $1.3 million in 2016, then soared by 71.89% to $2.2 million in 2017, then rose by 10.78% to $2.5 million in 2018, then grew by 20.36% to $3.0 million in 2019.
  • Business Quant data shows Non-Current Deffered Revenue for HQY at $3.0 million in Q1 2019, $2.5 million in Q2 2018, and $2.4 million in Q1 2018.